Delivery Order SPE2DR25D2205-SPE2DR26F2G04
Award Date 3/3/26
Potential Completion Date 3/24/26
Potential Value $8.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for $46,764.60 (ceiling value) to supply Imbruvica 420 mg tablets, 28-count units. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999 through December 2026, enabling supply of pharmaceutical products and medical supplies across multiple therapeutic domains to support...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $31,176.40 for supply of Imbruvica 420 mg tablets (28-count).</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 3, 2026. Pricing is firm fixed price. The delivery order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical.</p>
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of IMBRUVICA 420 MG TABLET 28S. The $7,322.67 contract has an ultimate completion date of October 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which allows the government to efficiently procure a...
- This is a $8,116.87 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, with a performance period ending on July 28, 2025. This delivery order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $8,116.87 delivery order to AmerisourceBergen Drug Corp for IMBRUVICA 140 mg capsules (90-count units) with a firm fixed price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of IMBRUVICA 420 mg tablets (28-count packages) with a ceiling value of $15,967.36. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract and is part of AmerisourceBergen's broader relationship with DLA as a critical pharmaceutical supplier. The contract is scheduled for ultimate completion on January 21,...
- The Defense Logistics Agency awarded a $10,460.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of the pharmaceutical IMBRUVICA 140 MG. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 8, 2023 through September 29, 2023. As the DLA supports the logistical needs of the Department of Defense, this delivery order was likely placed to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Imbruvica 140 mg capsules (120-count units) with a ceiling value of $22,810.50. This is a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, with a ceiling value of $31,176.40 for supply of Imbruvica 420 mg tablets (28-count).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. The order was issued under firm fixed-price terms with no set-aside.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a ceiling value of $24,350.61. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, was competitively awarded without a set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...